Medicines (Aristolochia) (Emergency Prohibition) Order 1999 c.2109

Medicines (Aristolochia) (Emergency Prohibition) Order 1999 No. 2109

Summary:

This Order prohibits the sale, supply, and importation, of medicinal products consisting of or containing a plant belonging to a species of the genus Aristolochia, or extracts from such a plant.

Those prohibitions are subject to the following exceptions -

(a) where the sale or supply is to, or the importation is made by or on behalf of, a person exercising functions in relation to the enforcement of food or medicines legislation;

(b) in the case of the prohibition on importation, where the products are imported from a member State of the European Community, or, where the products originate in a State party to the European Economic Area Agreement (EEA State), from an EEA State other than a member State,

(c) where the products are the subject of a product licence, marketing authorization or homoeopathic certificate of registration.

This Order was notified to the European Commission in accordance with European Parliament and Council Directive 98/34/EC (OJ No. L204, 22.7.1998, p.37/48) as amended by European Parliament and Council Directive 98/48/EC (OJ No. L217, 5.8.1998, p.18/26).

The Order shall come into force on 28th July 1999, and shall expire at the end of 27th October 1999.

Made Under:

Medicines Act 1968 (C. 67) - sections 62(1)(a), (2) and (3) and 129(6) and 129(7)

While Cardiff University has used all reasonable endeavours to ensure that information included in this Service is of high quality, no warranty, express or implied, is made as to the fitness for purpose and Cardiff University will not be held responsible for any consequence arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this Service do so strictly on the understanding that no liability whatsoever either direct or indirect shall rest upon Cardiff University for the effects of any act, product, process or method that may be effected, produced or adopted by any party, notwithstanding that the formulation of such act, product, process or method may be based upon use of this Service.